Applied DNA to Report Second Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, May 11, 2023

Rhea-AI Summary

Applied DNA Sciences, Inc. (NASDAQ: APDN) will release its financial results for the three months ended March 31, 2023 after the market close on May 11, 2023. The company will host a conference call at 4:30 p.m. ET on the same day to discuss the results and answer questions. The conference call will be available for replay for 7 days. An accompanying slide presentation will be embedded in the webcast and can be accessed on the Applied DNA website.

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release financial results for the three months ended March 31, 2023 after the market close on Thursday, May 11, 2023. The Company will host a conference call for the investment community to discuss the results and answer questions at 4:30 p.m. ET.

Date & Time: Thursday, May 11 @ 4:30 p.m. ET

Dial In:

• Domestic callers (toll free): 844-887-9402
• Canadian callers (toll free): 866-605-3852
• International callers: 412-317-6798
• Live webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=MRM611FN

A replay of the conference call will be available for 7 days following the conclusion of the call:

• Replay for domestic callers (toll free): 877-344-7529, replay access code 6050560
• Replay for international callers: 855-669-9658, replay access code 6050560

An accompanying slide presentation will be embedded in the webcast (live and replay) and can also be accessed in the ‘Company Events’ section under the ‘News & Events’ tab of the Applied DNA website at https://investors.adnas.com/. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

About Applied DNA Sciences

Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in three primary business markets: (i) the manufacture of DNA for use in nucleic acid-based therapeutics; (ii) the detection of DNA in molecular diagnostics testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company's common stock is listed on NASDAQ under the ticker symbol 'APDN,' and its publicly traded warrants are listed on OTC under the ticker symbol 'APPDW.'

View source version on businesswire.com: https://www.businesswire.com/news/home/20230503005914/en/

For additional information:

Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com

Web: www.adnas.com

Twitter: @APDN

Source: Applied DNA Sciences, Inc.

FAQ

When will Applied DNA Sciences release its financial results for the three months ended March 31, 2023?

Applied DNA Sciences will release its financial results on May 11, 2023.

What is the ticker symbol for Applied DNA Sciences?

The ticker symbol for Applied DNA Sciences is APDN.

What time will the conference call discussing the financial results be held?

The conference call will be held at 4:30 p.m. ET.

Where can I access the webcast of the conference call?

The webcast can be accessed at https://event.choruscall.com/mediaframe/webcast.html?webcastid=MRM611FN.

Will there be a replay of the conference call?

Yes, a replay of the conference call will be available for 7 days.

Where can I access the slide presentation accompanying the webcast?

The slide presentation can be accessed on the Applied DNA website under the 'Company Events' section of the 'News & Events' tab.